Organigram Holdings faces challenges after Health Canada’s edibles ruling

Mugglehead
By Zartasha MushtaqMar 27, 2024, 5:30 pm127 pts
In a recent development, Health Canada has delivered an unfavorable ruling to Organigram Holdings (NASDAQ: OGI). It is determining that its Edison Jolts lozenge cannabis products should be classified as edibles rather than extracts. This decision carries significant implications for Organigram’s product…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Legal Pot Delivery 101: A Beginner’s Guide to Cannabis at Your Door 57

Fluence Debuts SPYDR 3: Pioneering Fixture Upgrades Output and Efficiency for Cannabis Growers 56

Rhode Island Hemp Drinks Ban Bill Scaled Back To Instead Request Officials Make Recommendations For Intoxicating Product Rules 53

Business owners go to trial over THC ‘overdoses’ 51

What to Monitor When Starting CBD for Your Pet 49

Aurora Cannabis pays $215 million to acquire MedLeaf Therapeutics 49

Minnesota Officials Award State’s First Marijuana Business License 48

Why Seniors Are Driving the Clean Nutraceuticals Movement 47

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.